Jeena Sikho Lifecare Ltd vs Syncom Formulations India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Jeena Sikho Lifecare Ltd is ₹ 716.7 as of 05 May 15:30 . The P/E Ratio of Jeena Sikho Lifecare Ltd changed from 11.8 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 31 on March 2025 . This represents a CAGR of -9.49% over 4 years The Market Cap of Jeena Sikho Lifecare Ltd changed from ₹ 400.11 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 1546 crore on March 2025 . This represents a CAGR of 13.96% over 4 years The revenue of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 224.25 crore as compare to the Sep '25 revenue of ₹ 191.29 crore. This represent the growth of 17.23% The revenue of Syncom Formulations (India) Ltd for the Dec '25 is ₹ 120.64 crore as compare to the Sep '25 revenue of ₹ 126.97 crore. This represent the decline of -4.99% The ebitda of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 103.29 crore as compare to the Sep '25 ebitda of ₹ 93.47 crore. This represent the growth of 10.51% The ebitda of Syncom Formulations (India) Ltd for the Dec '25 is ₹ 26.71 crore as compare to the Sep '25 ebitda of ₹ 23.65 crore. This represent the growth of 12.94% The net profit of Jeena Sikho Lifecare Ltd changed from ₹ 15.73 crore to ₹ 66.6 crore over 7 quarters. This represents a CAGR of 128.11% The net profit of Syncom Formulations (India) Ltd changed from ₹ 7.63 crore to ₹ 18.91 crore over 7 quarters. This represents a CAGR of 67.97% The Dividend Payout of Jeena Sikho Lifecare Ltd changed from 8.19 % on March 2023 to 14.99 % on March 2025 . This represents a CAGR of 22.32% over 3 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Limited was originally incorporated as a Private Limited Company as 'Jeena Sikho Lifecare Private Limited' dated May 29, 2017 issued by the Registrar of Companies, Delhi.
Subsequently, the Company got the status converted into Public Limited Company and the name was changed to 'Jeena Sikho Lifecare Limited' dated July 05, 2021, via fresh Certificate of Incorporation. Jeena Sikho Lifecare Limited is a renowned Ayurvedic healthcare company headquartered in Zirakpur, Punjab.
The Company is one of the leading ayurvedic healthcare system providers in India.
The Company is selling more than 250 Herbal/ Ayurvedic products.
The Company conducts various health checkup camps, yoga sessions to make people aware of their health problems as well.

About Syncom Formulations (India) Ltd

Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

FAQs for the comparison of Jeena Sikho Lifecare Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, Jeena Sikho Lifecare Ltd or Syncom Formulations (India) Ltd?

Market cap of Jeena Sikho Lifecare Ltd is 8,908 Cr while Market cap of Syncom Formulations (India) Ltd is 1,321 Cr

What are the key factors driving the stock performance of Jeena Sikho Lifecare Ltd and Syncom Formulations (India) Ltd?

The stock performance of Jeena Sikho Lifecare Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jeena Sikho Lifecare Ltd and Syncom Formulations (India) Ltd?

As of May 5, 2026, the Jeena Sikho Lifecare Ltd stock price is INR ₹716.7. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹14.06.

How do dividend payouts of Jeena Sikho Lifecare Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of Jeena Sikho Lifecare Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.